Health

Amazon’s over-the-counter drugs are less expensive than CVS, Walgreens

Amazon is usually competing with drugstores where This specific’s known to win: cost. The e-commerce giant quietly launched a line of private-label over-the-counter drugs in August. Called Basic Care, the product line includes about 60 products ranging through ibuprofen to hair regrowth treatment. The products are produced by Perrigo, yet serve as Amazon’s store brand. Jefferies compared prices between these ...

Read More »

France’s love affair with cigarettes could go up in smoke

PARIS – The glamorous image of cool Parisians lighting up Gauloises while lingering at an outdoor cafe may soon go up in smoke. The French government is usually stubbing out the country’s love affair with tobacco. “In France, tobacco kills 0 people every day,” Health Minister Agnes Buzyn said in May. “We need to continue This kind of fight against ...

Read More »

Seniors could gain access to fee-based doctors under a brand-new plan

Health in addition to Human Service Secretary Alex Azar has proposed possibly giving some Medicare patients a stipend to help them gain access to fee-based practices in which provide more personalized care. “Arrangements like direct primary care have generated tremendous interest by both patients in addition to providers. They can offer the opportunity for seniors to receive convenient, accessible primary ...

Read More »

Juul e-cigarette sales have surged over the past year

Yet as Juul’s sales have increased, so has public scrutiny. The devices are favorite with young people who can hide the sleek devices via parents along with teachers. Pods filled with nicotine liquids are available in sweet flavors like creme brulee along with mango, which critics say appeal to young people, not the adult smokers Juul says This specific’s trying ...

Read More »

When analysts say sell a biotech stock, of which’s time to buy

Cowen’s analysis comes at a time, the team pointed out, when the way investors use as well as compensate sell-side analysts is actually changing. They noted institutional investors are evaluating how they use sell-side services as well as how much value they provide. of which also comes as the mood among investors in biotech, specifically, “is actually not particularly rosy,” ...

Read More »